Emerging Treatment Modalities in Metastatic Breast Cancer: Highlights from SABCS 2022 and Beyond - Episode 2
Standards of Care in the Frontline Treatment of ER+/HER2- mBC
Komal Jhaveri, MD, FACP, explains data on the frontline standard of care treatment approaches for ER-positive HER2-negative mBC.
Related Content:
